Clinical trial registry record

Frailty Evaluation in Elderly Population With Cancer

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated May 30, 2017.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03101631
Last registry update
May 30, 2017
Status
Completed
Phase
Phase not reported
Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Enrollment
62
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NON RANDOMIZED · PARALLEL · SCREENING · NONE
Evidence population
Human clinical study registration
Participants
62
Population
ALL · 70 Years
Duration
2014-01-02 to 2015-01-30
Intervention
Comprehensive Geriatric Assessment (CGA)
Comparator
CONTROL ARM
Outcomes measured
Number of participants with treatment related adverse events as assessed by CTCAE v4.0 — 6 months; Number of participants with occurrence of early mortality — 6 months; Number of Hospitalizations — 6 months; Number of participants with changes in cancer treatment related to toxicity — 6 months; Number of participants with a change in therapeutic decision related to CGA — 6 months; Contribution of different components of CGA to the management fo cancer — 6 months; Impact of CGA in health care in terms of human recourses and time consumption — Baseline; Predictive factors of events related to treatment — 6 months
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cancer and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
  • Frailty · 80%Title contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

cancer and agingfrailty
Read the original source →Export JSON